Doctor Margaret Sketch
United Therapeutics Corporation, Research Triangle Park (United States of America)
Change in REVEAL Lite 2 and COMPERA 2.0 risk status in patients with pulmonary arterial hypertension initiating oral treprostinil on dual background therapy: a retrospective chart review
Event: ESC Congress 2022
Topic: Pulmonary Hypertension
Session: Treatment of pulmonary arterial hypertension: the old and the new
ESC 365 is supported by
